Note - Changes in the scope of control
Pages: 47 to 47
Creation Date: 1965/01/01
The international treaties on narcotic drugs make provision for placing new narcotic drugs under international control, by means of a procedure which involves Governments, the Secretary-General of the United Nations, the World Health Organization and the Commission on Narcotic Drugs. The procedure may be applied not only in respect of the extension of control to new drugs, but also in respect of exemption from control of drugs of their preparations.
The international procedure for extending control to new drugs is put into motion upon an application being made by a government to the Secretary-General of the United Nations, who transmits it immediately to Governments and the World Health Organization. The latter subsequently decides whether the substance considered is capable of producing addiction or is convertible into such a substance. It also decides on the control regime to be applied to the drug. [ 1] The decision is ultimately communicated by the Secretary-General of the United Nations to all Governments, [ 2] whereupon the drug in question enters the control system.
During 1964, several requests were received from Governments concerning extension of control to new substances, and the World Health Organization took the following decision: 1-(3-cynao-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide and its salts (international non-proprietary name proposed for piritramide) in reference of which a notification had been made by the Governments of Belgium and France, should be placed under the regime of control laid down in the 1931 Convention, article 1, para. 2, group I.
The World Health Organization decided to postpone the decision concerning the following drug for lack, at present, of sufficient information, according to the above-mentioned Organization's Expert Committee on Dependence-producing Drugs: 6-nicotinyldihydrocodeine (international non-proprietary name proposed for nicocodine). The World Health Organization also decided that certain preparations containing diphenoxylate should remain under international control (requests for exemption of those preparations from international control emanated from Governments of Belgium and from Great Britain). At its nineteenth session, the Commission on Narcotic Drugs agreed that the following amendments be made to the tables of the Single Convention proposed by the World Health Organization.
The following items should be added:
Methadone-intermediate [4-cyano-2-dimethylamino-4,4- diphenylbutane];
Moramide-intermediate [2-methyl-3-morpholino- 1,1-di- phenylpropane-carboxylic acid];
Noracymethadol [( +)-alpha-3-acetoxy-6-methylamino-4, 4-diphenylheptane];
Pethidine-intermediate-A [4-cyano- 1-methyl-4-phenylpi- peridine];
Pethidine-intermediate-B[4-phenylpiperidine-4-carboxy- lic acid ethyl ester];
Pethidine-intermediate-C [1-methyl-4-phenylpiperidine- 4-carboxylic acid].
Nicocodine (6-nicotinylcodeine)should be added.
Dextropropoxyphene [(4-)-4-dimethylamino-3-methyl- 1,2-diphenyl-2-propionoxybutane] should be deleted.
Of the substances listed in section (1), dextropropoxyphene should be deleted.
Finally, upon recommendation of the World Health Organization, in accordance with article 3, para. 1 of the Single Convention on Narcotic Drugs, 1961, the Commission on Narcotic Drugs, at its twentieth session, decided that piritramide would be included in table I of the said Convention.1
It should be noted that, in accordance with the Single Convention on Narcotic Drugs, 1961, the final decision does not rest with the World Health Organization but with the Commission on Narcotic Drugs which acts on the recommendation made by WHO.2
According to the Single Convention on Narcotic Drugs, 1961, the final decision has to be communicated by the Secretary-General to all States Members of the United Nations Organization, to the States non-members Parties to the Convention, to the World Health Organization and to the International Narcotics Control Board.